Keyphrases
Atrial Fibrillation
100%
Edoxaban
100%
Asian Patients
100%
Warfarin
81%
Confidence Interval
45%
Hazard Ratio
45%
Hospitalization
36%
All-cause Mortality
36%
Major Bleeding
27%
Risk of Ischemic Stroke
27%
Risk Reduction
18%
New User
18%
Propensity Score Match
18%
Gastrointestinal Bleeding
18%
CHA2DS2-VASc Score
18%
Intracranial Hemorrhage
18%
Non-valvular Atrial Fibrillation
9%
Bleeding
9%
High Risk
9%
Hypertension
9%
Diabetes Mellitus
9%
Clinical Outcome
9%
Congestive Heart Failure
9%
Low Risk
9%
Thromboembolism
9%
Ischemic Stroke
9%
Prior Stroke
9%
Transient Ischemic Attack
9%
Mortality Hazard
9%
Renal Function
9%
Vascular Disease
9%
Matched Cohort
9%
Baseline Characteristics
9%
Asian Population
9%
National Health Insurance Service
9%
Korean National Health Insurance
9%
Korean Population
9%
Pharmacology, Toxicology and Pharmaceutical Science
Edoxaban
100%
Warfarin
81%
Atrial Fibrillation
45%
Brain Ischemia
36%
Cause of Death
27%
Bleeding
18%
Brain Hemorrhage
18%
Gastrointestinal Hemorrhage
18%
Diabetes Mellitus
9%
Congestive Heart Failure
9%
All Cause Mortality
9%
Thromboembolism
9%
Transient Ischemic Attack
9%
Vascular Disease
9%